You are viewing an expired study

This study is not currently recruiting Study Participants on ClinicalConnection.com. If you would like to find active studies please browse nearby listings below.

Click here to view additional nearby studies or search for clinical trials.

Morgantown, West Virginia 26505

  • Hypertension

Purpose:

The purpose of this study is to determine the effects on exercise capacity of nebivolol compared to atenolol in hypertensive patients.


Study summary:

This was a pilot, phase II, double-blind, randomized, muticenter, active-comparator, five treatment parallel group dosing and mechanistic study. The study consisted of two phases: 1) screen/washout/single-blind placebo run-in and 2) randomization/treatment. There was a minimum of five scheduled study visits.


Criteria:

Inclusion Criteria: - An average sitting diastolic blood pressure (DBP) of greater then or equal to 95 mmHg and less then or equal to 109 mmHg at baseline Exclusion Criteria: - Recent myocardial infarction or stroke - Secondary Hypertension - Contraindications to beta-blocker therapy or stopping prior antihypertensive therapy


NCT ID:

NCT00200421


Primary Contact:

Study Director
Betty S. Riggs, MD, MBA
Mylan Pharmaceuticals


Backup Contact:

N/A


Location Contact:

Morgantown, West Virginia 26505
United States



There is no listed contact information for this specific location.

Site Status: N/A


Data Source: ClinicalTrials.gov

Date Processed: March 30, 2020

Modifications to this listing: Only selected fields are shown, please use the link below to view all information about this clinical trial.


Click to view Full Listing

This study is not currently recruiting Study Participants on ClinicalConnection.com. The form below is not enabled.